Product Categories
| Country: | China |
|---|---|
| Tel: | 028-64841719 |
| Mobile: | 15680023009 |
| E-mail: | daisy@enlaibio.com |
| QQ: | 2777524105 |
| Skype: | Chat Now! |
| Address: | A38-2, No. 66, Nanhu road, Deyang City, Sichuan Province (Jiuwei Blue Valley) |
|
Sichuan HongRi Pharma-Tech Co.,Ltd(Enlai Biotech)is a high-tech technology enterprise approved by the Chengdu Municipal Government and is a private enterprise specializing in the development,production and sales of natural amino acids,non-natural amino acids,amino acid derivatives,peptides,pharmaceutical intermediates,pharmaceutical raw materials and raw pharmaceutical.
We have a professional and experienced R&D and production management team composed by returnees,MD,MS,university professors,and senior engineers who have rich experience in industry practices.We use different models of production equipment(specification coverage:gram to ton),standard R&D lab and workshop,comprehensive detecting instruments and equipment(including:HPLC,GC,HNMR,etc.)and efficient management system to ensure the best product quality.Our products are widely accepted and appreciated by not only domestic industry institutes and enterprises,but also those in Europe and US.
Our philosophy: Innovation, Honesty and Integrity, Contribute to the present society and later ages. Our aim: people-oriented, common development. We are working hard to provide a good platform and development space for employees, and to best fit the customers'needs with high quality and valued products. We are sincerely willing to work with you to development, go hand in hand and create brilliant future!
|
|
| Product Name | MF | CAS | Details |
|---|
| 6-(4-Aminophenyl)-4,5-dihydro-5-methyl-3(2H)-pyridazinone | C11H13N3O | 36725-28-7 | Details |
| 1-Bromo-2-methoxy-3-nitro-benzene | C7H6BrNO3 | 98775-19-0 | Details |
| TDF-LA-M2 | C22H19ClN2O5 | 629652-42-2 | Details |
| LevosiMendan iMpurity | 139052-02-1 | Details |
| TDF-N-YBC | C24H23N3O5 | 1353020-85-5 | Details |
| API-methyl ester impurity | C26H24N4O4 | 1246929-01-0 | Details |
| EZ-422 | C20H18F4N4O2 | 1289942-55-7 | Details |
| EP-I | C22H19N3O5 | 1795790-92-9 | Details |
| TDF-DA-M2-COOH impurity | C21H17ClN2O5 | 2058231-08-4 | Details |
| Enzalutamide Impurity 7 | C21H18F4N4O3S | /2030242-21-6 | Details |
| TDF-DA-M1 | C20H19ClN2O4 | 171752-68-4 | Details |
| EZLA-ZZA-O | Details |
| DB-M2 | C22H19ClN2O5 | 629652-40-0 | Details |
| TDF-DA-ethanoyl -M1 | C22H20N2O5 | 1598416-05-7 | Details |
| Etrapopa Ethanolamine impurity | C26H24N4O4 | 1437383-35-1 | Details |
| 53692T | C23H21ClN2O5 | 1863191-32-5 | Details |
| AQ-M1-JM | C14H13NO3 | 1176777-76-6 | Details |
| D3-EZ-S2 | C9H3F3N2S | 143782-23-4 | Details |
| D3-EZLA-TF-M1（H1） | Details |
| TDF-LB-M2 | C22H19ClN2O5 | 629652-44-4 | Details |
| Malononitrile | C3H2N2 | 109-77-3 | Details |
| TDF-M1-JXA impurity | C20H19N3O3 | 951661-82-8 | Details |
| M2-ZA05 | C25H21ClN4O4 | 376592-56-2 | Details |
| EZLA-2JXA | C22H18F4N4O2S | 1443331-78-9 | Details |
| Levosimendan Impurity 8 | C14H14N6O2 | 274263-65-9 | Details |
| (S)-3(2h)-Pyridazinone, 6-(4-Aminophenyl)-4,5-Dihydro-5-Methyl- | C11H13N3O | 101328-84-1 | Details |
| TDF-YJ-M2 | C21H21ClN2O4 | 1158815-27-0 | Details |
| API-ZZE | Details |
| N-[4-(2-bromopropanoyl)phenyl]acetamide | C11H12BrNO2 | 63514-63-6 | Details |
| TDF-LA-M1 | C20H18N2O4 | 171596-43-3 | Details |
| EP-A（LB） | C22H19N3O4 | 171596-27-3 | Details |
| N-desMethyl EnzalutaMide | C20H14F4N4O2S | 1242137-16-1 | Details |
| D3-EZLA-M2 | C20H13F4N3O3S | 1242137-15-0 | Details |
| TDF-API-2JM | C23H23N3O4 | 1356345-67-9 | Details |
| Levosimendan-001 | C11H14N4O | 244077-42-7 | Details |
| EP-E | C22H19N3O6 | 2520114-41-2 | Details |
| TDF-M2 | C22H19ClN2O5 | 171489-59-1 | Details |
| EZLA-M2 | Details |
| TDF-LB-M1 | C20H18N2O4 | 171596-44-4 | Details |
| TDF-DB-M1 | C20H18N2O4 | 171596-42-2 | Details |
| TDF-DB-M2-JXA | C22H20ClN3O4 | 951661-84-0 | Details |
| Levosimendan | C14H12N6O | 141505-33-1 | Details |
| TDF-M2-2YA | C26H29N3O5 | 1588526-67-3 | Details |
| Dimethylamine derivative impurity | C24H25N3O5 | 2169996-11-4 | Details |
| EZ-S3-2J-O | C17H8F6N4O | 1895865-11-8 | Details |
| 2,3-(METHYLENEDIOXY)BENZALDEHYDE | C8H6O3 | 7797-83-3 | Details |
| Propanedinitrile, 2-[2-[4-(1,6-dihydro-4-methyl-6-oxo-3-pyridazinyl)phenyl]hydrazinylidene]- | C14H10N6O | 131741-36-1 | Details |
| D-Tryptophan, N-(trifluoroacetyl)- (9CI) | C13H11F3N2O3 | 22220-03-7 | Details |
| Etrapopa Ethanolamine impurity 8 | C27H27N5O4 | 2587607-84-7 | Details |
| M1-ZA01 | 1418987-67-0 | Details |
| NA | 1489977-24-8 | Details |
| (R,E)-2-cyano-2-(2-(4-(4-methy1-6-oxo-1,4,5,6-tetrahydropyridazin-3-yl)phenyl)hydrazono)acetic acid | Details |
| API-ZZD | Details |
| Enzalutamide | C21H16F4N4O2S | 915087-33-1 | Details |
| EP-C（DB） | C22H19N3O4 | 171596-28-4 | Details |
| diethyl 2-(1-(4-acetaMidophenyl)-1-oxopropan-2-yl)Malonate | C18H23NO6 | 81937-39-5 | Details |
| EZLA-API | C21H17F3N4O2S | 915087-16-0 | Details |
| TDF-ZZS/TDF-2J-M1-COOH | C38H28N4O6 | 1598416-03-5 | Details |
| Thiourea, N-[4-cyano-3-(trifluoromethyl)phenyl]- | C9H6F3N3S | 1415552-04-3 | Details |
| (R)-6-(4-Aminophenyl)-4,5-dihydro-5-methyl-3(2H)-pyridazinone | C11H13N3O | 101328-85-2 | Details |
| 3(2H)-Pyridazinone, 4,5-dihydro-5-methyl-6-phenyl-, (5R)- | C11H12N2O | 1630760-89-2 | Details |
| ZX-R-JXM2 | Details |
| M1 | C13H11NO3 | 376592-93-7 | Details |
| EP-B（LA） | C22H19N3O4 | 629652-72-8 | Details |
| D3-EZLA-S1 | C13H16FNO4 | 1802242-47-2 | Details |
| 4-((2-carboxypropan-2-yl)amino)-2-fluorobenzoic acid| (API-ZZJ) | C11H12FNO4 | 1332524-02-3 | Details |
| API acid amides | C25H23N5O3 | 1246929-02-1 | Details |
| TDF-KH-JXACOOH-HCl（T007037） | C22H21N3O5 | 2058231-15-3 | Details |
| Levosimendan Impurity 4 | C14 H14 N6 O2 | 131741-37-2 | Details |
| Levosimendan | C11H11ClN2O | 36725-41-4 | Details |
| D3-EZ-M2-SJXA | Details |
| 3-(2-Hydroxyphenyl)benzoic acid | C13H10O3 | 893736-72-6 | Details |
| 2-HYDROXY-3''-NITRO-BIPHENYL-3-CARBOXYLIC ACID | C13H9NO5 | 376591-95-6 | Details |
| 4-(4-acetamidophenyl)-3-methyl-4-oxobutanoic acid | C13H15NO4 | 36725-26-5 | Details |
| API | C27H29N5O5 | 496775-62-3 | Details |
| 2-(1-(4-acetaMidophenyl)-1-oxopropan-2-yl)Malonic acid | C14H15NO6 | 1221499-54-2 | Details |
| TDF-M2-Formamide impurity | C22H20ClN3O4 | 951661-81-7 | Details |
| TDF-YXA | C23H20N4O5 | 1446144-71-3 | Details |
| EZLA:S3-2J-S | C17H8F6N4S | 1839619-50-9 | Details |
| D3-EZLA-M1 | C21H15F4N3O3S | 1802242-43-8 | Details |
| DA-M2-2Cl impurity | C22H18Cl2N2O5 | 1598416-08-0 | Details |
| EICOSANEDIOIC ACID | C20H38O4 | 2424-92-2 | Details |
| TDF-M1-COOH | C19H16N2O4 | 406938-39-4 | Details |
| Levosimendan Impurity 10 | C11H12N2O2 | 134678-47-0 | Details |
| S2-Z01 | C14H18N2O | 2500321-37-7 | Details |
| Tryptophan-002 | C12H11N3O2 | 40856-80-2 | Details |
| 3(2H)-Pyridazinone, 6-(4-chlorophenyl)-4,5-dihydro-5-methyl-, (5R)- | C11H11ClN2O | 1630760-90-5 | Details |
| D3-EZLA-TF-M2（H2） | Details |
| Demethyltadalafil impurity | C21H17N3O4 | 171596-36-4 | Details |
| EZLA-M1 | C12H15FN2O3 | 1289942-66-0 | Details |
| TDF-DB-M1-JXA | C20H19N3O3 | 951661-85-1 | Details |
| N-ethyl TDF | C23H21N3O4 | 1609405-34-6 | Details |
| 2'-Methoxy-3'-nitro-biphenyl-3-carboxylic acid | C14H11NO5 | 376591-94-5 | Details |
| N-[4-(AMinocarbonyl)-3-fluorophenyl]-2-Methylalanine | C11H13FN2O3 | 1242137-20-7 | Details |
| 4-Amino-2-(trifluoromethyl)benzonitrile | C8H5F3N2 | 654-70-6 | Details |
| Levosimendan Impurity 2 | C11H12N2O2 | 103416-88-2 | Details |
| Oxo Enzalutamide | C21H16F4N4O3 | 1242137-18-3 | Details |
| Levosimendan Impurity 14 | C14H12N6O | 144238-75-5 | Details |
| EZLA-API-ZZA | C10H7F3N2OS | 1895865-10-7 | Details |
| 4-(4-Aminophenyl)-3-methyl-4-oxobutanoic acid | C11H13NO3 | 42075-29-6 | Details |
| Product Total： Product Page： | ||||
| 1 2 3 4 5 6 7 8 9 10 11 12 13 14 | ||||